- Home
- REAX vs ELVN Comparison
REAX vs ELVN Comparison
Compare REAX & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAX
- ELVN
- Stock Information
- Founded
- REAX 2018
- ELVN 2016
- Country
- REAX United States
- ELVN United States
- Employees
- REAX N/A
- ELVN N/A
- Industry
- REAX
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- REAX
- ELVN Health Care
- Exchange
- REAX Nasdaq
- ELVN Nasdaq
- Market Cap
- REAX 909.7M
- ELVN 842.4M
- IPO Year
- REAX N/A
- ELVN 2020
- Fundamental
- Price
- REAX $4.59
- ELVN $18.21
- Analyst Decision
- REAX Strong Buy
- ELVN Strong Buy
- Analyst Count
- REAX 2
- ELVN 4
- Target Price
- REAX $6.00
- ELVN $39.25
- AVG Volume (30 Days)
- REAX 867.7K
- ELVN 358.4K
- Earning Date
- REAX 05-08-2025
- ELVN 05-13-2025
- Dividend Yield
- REAX N/A
- ELVN N/A
- EPS Growth
- REAX N/A
- ELVN N/A
- EPS
- REAX N/A
- ELVN N/A
- Revenue
- REAX $1,264,639,000.00
- ELVN N/A
- Revenue This Year
- REAX $38.54
- ELVN N/A
- Revenue Next Year
- REAX $17.98
- ELVN N/A
- P/E Ratio
- REAX N/A
- ELVN N/A
- Revenue Growth
- REAX 83.50
- ELVN N/A
- 52 Week Low
- REAX $3.35
- ELVN $13.30
- 52 Week High
- REAX $6.75
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- REAX 52.51
- ELVN 49.35
- Support Level
- REAX $4.41
- ELVN $17.36
- Resistance Level
- REAX $4.99
- ELVN $19.61
- Average True Range (ATR)
- REAX 0.25
- ELVN 1.88
- MACD
- REAX 0.04
- ELVN 0.26
- Stochastic Oscillator
- REAX 61.17
- ELVN 76.84
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.